Long COVID risk found to be significantly lower following Omicron infection

The risk of developing long COVID is significantly lower following an infection with the Omicron variant than after an infection with earlier coronavirus variants.

DEFENCE THERAPEUTICS GRANTED CNRI-H FROM THE CANADIAN NUCLEAR LABORATORIES TO ACCELERATE THE DEVELOPMENT OF ITS RADIO-IMMUNO-CONJUGATES PROGRAM – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE THERAPEUTICS GRANTED CNRI-H FROM THE CANADIAN NUCLEAR LABORATORIES TO ACCELERATE THE DEVELOPMENT OF ITS RADIO-IMMUNO-CONJUGATES PROGRAM

July 25, 2024

Prostate Cancer Treatment Associated With Long-Term Complications

Even accounting for age-related symptoms and disease, treatment of prostate cancer came with higher rates of complications associated with worse quality of life and new

November 8, 2024

IGC Pharma obtains funds to boost Alzheimer’s research

The company’s IGC-AD1 is being evaluated in a Phase II trial to treat agitation in patients with Alzheimer’s associated dementia. Credit: Giovanni Cancemi via Shutterstock.com.

July 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.